Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.8357 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Hilary Baldwin und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Clindamycin, Gels, Drug Combinations. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Baldwin, H., Gold, L. S., Harper, J. C., Alexis, A. F., Callender, V. D., Kircik, L., Guenin, E., & Eichenfield, L. F. (2024). Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8357
Vancouver
Baldwin H, Gold LS, Harper JC, Alexis AF, Callender VD, Kircik L, et al. Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8357
BibTeX
@article{Baldwin2024,
author = {Baldwin, Hilary and Gold, Linda Stein and Harper, Julie C and Alexis, Andrew F and Callender, Valerie D and Kircik, Leon and Guenin, Eric and Eichenfield, Lawrence F},
title = {Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.8357}
}
EUVIMED